Paul Zarkowski

Guest Paul Zarkowski, a faculty member at the Psychopharmacology Institute, discusses a groundbreaking Israeli study on tapering benzodiazepines in elderly hospital patients. He highlights the significant risks associated with prolonged use, including falls and cognitive decline. The study's two interventions show modest success in encouraging medication discontinuation. Zarkowski emphasizes the importance of patient education, proper tapering protocols, and communication between physicians to improve long-term outcomes and care continuity for this vulnerable population.

Dr. Paul Zarkowski, a faculty member specializing in the risks associated with benzodiazepines, discusses a groundbreaking French study revealing the complex link between these anxiety medications and suicide risk. The conversation highlights how benzodiazepines, while effective for anxiety, may inadvertently increase impulsivity and risk among vulnerable patients. Zarkowski advocates for cautious prescribing and thorough patient assessments, particularly for those undergoing significant life changes, to ensure safer treatment outcomes.